These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

474 related articles for article (PubMed ID: 27598348)

  • 1. Management of Sickle Cell Disease in Children.
    Noronha SA; Sadreameli SC; Strouse JJ
    South Med J; 2016 Sep; 109(9):495-502. PubMed ID: 27598348
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Hydroxyurea therapy in children severely affected with sickle cell disease.
    Scott JP; Hillery CA; Brown ER; Misiewicz V; Labotka RJ
    J Pediatr; 1996 Jun; 128(6):820-8. PubMed ID: 8648542
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Hydroxyurea therapy: improving the lives of patients with sickle cell disease.
    Anderson N
    Pediatr Nurs; 2006; 32(6):541-3. PubMed ID: 17256291
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Chronic Administration of Hydroxyurea (HU) Benefits Caucasian Patients with Sickle-Beta Thalassemia.
    Di Maggio R; Hsieh MM; Zhao X; Calvaruso G; Rigano P; Renda D; Tisdale JF; Maggio A
    Int J Mol Sci; 2018 Feb; 19(3):. PubMed ID: 29495591
    [TBL] [Abstract][Full Text] [Related]  

  • 5. The clinical care of adult patients with sickle cell disease.
    Olujohungbe A; Howard J
    Br J Hosp Med (Lond); 2008 Nov; 69(11):616-9. PubMed ID: 19069260
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Hydroxyurea in Pediatric Patients With Sickle Cell Disease: What Nurses Need to Know.
    Rees AL
    J Pediatr Oncol Nurs; 2016 Sep; 33(5):339-44. PubMed ID: 26611755
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Sickle Cell Disease: A Review.
    Kavanagh PL; Fasipe TA; Wun T
    JAMA; 2022 Jul; 328(1):57-68. PubMed ID: 35788790
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Treatment Options for Sickle Cell Disease.
    Meier ER
    Pediatr Clin North Am; 2018 Jun; 65(3):427-443. PubMed ID: 29803275
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Novel approaches to the treatment of sickle cell disease: the potential of histone deacetylase inhibitors.
    Okam MM; Ebert BL
    Expert Rev Hematol; 2012 Jun; 5(3):303-11. PubMed ID: 22780210
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Management of sickle cell disease: summary of the 2014 evidence-based report by expert panel members.
    Yawn BP; Buchanan GR; Afenyi-Annan AN; Ballas SK; Hassell KL; James AH; Jordan L; Lanzkron SM; Lottenberg R; Savage WJ; Tanabe PJ; Ware RE; Murad MH; Goldsmith JC; Ortiz E; Fulwood R; Horton A; John-Sowah J
    JAMA; 2014 Sep; 312(10):1033-48. PubMed ID: 25203083
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Clinical Features of β-Thalassemia and Sickle Cell Disease.
    McGann PT; Nero AC; Ware RE
    Adv Exp Med Biol; 2017; 1013():1-26. PubMed ID: 29127675
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Sickle cell disease: current treatment and emerging therapies.
    Neumayr LD; Hoppe CC; Brown C
    Am J Manag Care; 2019 Nov; 25(18 Suppl):S335-S343. PubMed ID: 31809007
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Sickle Cell Disease: A Primer for Primary Care Providers.
    Kimrey S; Saving KL
    Pediatr Ann; 2020 Jan; 49(1):e43-e49. PubMed ID: 31930422
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Neonatal Screening and the Clinical Outcome in Children with Sickle Cell Disease in Central India.
    Upadhye DS; Jain DL; Trivedi YL; Nadkarni AH; Ghosh K; Colah RB
    PLoS One; 2016; 11(1):e0147081. PubMed ID: 26785407
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Original Research: Parvovirus B19 infection in children with sickle cell disease in the hydroxyurea era.
    Hankins JS; Penkert RR; Lavoie P; Tang L; Sun Y; Hurwitz JL
    Exp Biol Med (Maywood); 2016 Apr; 241(7):749-54. PubMed ID: 26940953
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Hydroxyurea for children with sickle cell disease.
    Heeney MM; Ware RE
    Pediatr Clin North Am; 2008 Apr; 55(2):483-501, x. PubMed ID: 18381097
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Effect of hydroxyurea in sickle cell anemia: a clinical trial in children and teenagers with severe sickle cell anemia and sickle cell beta-thalassemia.
    Koren A; Segal-Kupershmit D; Zalman L; Levin C; Abu Hana M; Palmor H; Luder A; Attias D
    Pediatr Hematol Oncol; 1999; 16(3):221-32. PubMed ID: 10326220
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Sickle-cell disease.
    Rees DC; Williams TN; Gladwin MT
    Lancet; 2010 Dec; 376(9757):2018-31. PubMed ID: 21131035
    [TBL] [Abstract][Full Text] [Related]  

  • 19. New therapies and approaches to transfusion in sickle cell disease in children.
    Styles LA; Vichinsky EP
    Curr Opin Pediatr; 1997 Feb; 9(1):41-5. PubMed ID: 9088754
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Clinical Practice Patterns in Sickle Cell Disease Treatment: Disease-modifying and Potentially Curative Therapies.
    Sánchez LM; Morrone K; Frei-Jones M; Fasipe TA
    J Pediatr Hematol Oncol; 2024 Jul; 46(5):e277-e283. PubMed ID: 38718300
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 24.